| Secondary |
| Product Used For Unknown Indication |
58.5% |
| Cardiac Failure |
8.3% |
| Hypertension |
6.7% |
| Drug Use For Unknown Indication |
6.5% |
| Benign Prostatic Hyperplasia |
3.4% |
| Cardiac Failure Chronic |
2.1% |
| Cardiovascular Event Prophylaxis |
2.1% |
| Arrhythmia |
1.5% |
| Diabetes Mellitus |
1.4% |
| Abdominal Pain Upper |
1.0% |
| Atrial Fibrillation |
1.0% |
| Cardiac Failure Congestive |
1.0% |
| Oedema Peripheral |
1.0% |
| Thrombosis Prophylaxis |
1.0% |
| Depression |
0.9% |
| Pemphigoid |
0.9% |
| Bipolar Disorder |
0.7% |
| Hyperuricaemia |
0.7% |
| Vertigo |
0.7% |
| Arthralgia |
0.5% |
|
| Fall |
21.8% |
| Hyponatraemia |
10.3% |
| Renal Failure Acute |
10.3% |
| Vomiting |
7.7% |
| Toxic Skin Eruption |
6.4% |
| Hypokalaemia |
5.1% |
| Hypotension |
3.8% |
| Rash |
3.8% |
| Diarrhoea |
2.6% |
| Eosinophilia |
2.6% |
| Hepatitis |
2.6% |
| Iatrogenic Injury |
2.6% |
| Orthostatic Hypotension |
2.6% |
| Pruritus |
2.6% |
| Renal Failure |
2.6% |
| Rhabdomyolysis |
2.6% |
| Subdural Haematoma |
2.6% |
| Thrombocytopenia |
2.6% |
| Transaminases Increased |
2.6% |
| Vitamin B12 Increased |
2.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
17.1% |
| Drug Use For Unknown Indication |
13.8% |
| Prophylaxis |
10.1% |
| Cardiac Failure |
8.2% |
| Hypertension |
7.0% |
| Diabetes Mellitus |
5.0% |
| Angina Pectoris |
4.9% |
| Atrial Fibrillation |
4.7% |
| Depression |
4.7% |
| Thrombosis Prophylaxis |
4.2% |
| Unevaluable Event |
4.2% |
| Ill-defined Disorder |
2.7% |
| Cardiac Failure Chronic |
2.3% |
| Anxiety |
2.0% |
| Coronary Artery Disease |
1.6% |
| Diverticular Perforation |
1.6% |
| Hypercholesterolaemia |
1.6% |
| Cough |
1.5% |
| Prophylaxis Against Renal Transplant Rejection |
1.5% |
| Rheumatoid Arthritis |
1.4% |
|
| Tremor |
14.0% |
| Renal Failure Acute |
11.2% |
| Peritoneal Haemorrhage |
9.1% |
| Renal Failure |
7.0% |
| Myocardial Infarction |
6.3% |
| Thrombocytopenia |
6.3% |
| Vomiting |
5.6% |
| Cardiac Failure |
4.2% |
| Pneumonia |
4.2% |
| Pyrexia |
3.5% |
| Rash |
3.5% |
| Cardiac Arrest |
2.8% |
| Diarrhoea |
2.8% |
| General Physical Health Deterioration |
2.8% |
| Human Herpesvirus 8 Infection |
2.8% |
| Interstitial Lung Disease |
2.8% |
| Lung Disorder |
2.8% |
| Malaise |
2.8% |
| Neutropenia |
2.8% |
| Osteonecrosis |
2.8% |
|
| Interacting |
| Cardiomyopathy |
46.2% |
| Atrial Fibrillation |
30.8% |
| Hypothyroidism |
15.4% |
| Benign Prostatic Hyperplasia |
7.7% |
|
|
